{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:43:35Z","timestamp":1770918215765,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10620-021-07040-z","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T03:42:20Z","timestamp":1620790940000},"page":"2067-2073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients\u2019 Survey"],"prefix":"10.1007","volume":"67","author":[{"given":"B\u00e9n\u00e9dicte","family":"Caron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Neuville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-6618","authenticated-orcid":false,"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"7040_CR1","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.3390\/jcm9113533","volume":"9","author":"M Allocca","year":"2020","unstructured":"Allocca M, Chaparro M, Gonzalez HA et al. Patients with inflammatory bowel disease are not at increased risk of COVID-19: a large multinational cohort study. J Clin Med 2020;9:3533.","journal-title":"J Clin Med"},{"key":"7040_CR2","doi-asserted-by":"publisher","first-page":"S798","DOI":"10.1093\/ecco-jcc\/jjaa160","volume":"14","author":"F Magro","year":"2020","unstructured":"Magro F, Rahier J-F, Abreu C et al. Inflammatory bowel disease management during the COVID-19 outbreak: the ten do\u2019s and don\u2019ts from the ECCO-COVID taskforce. J Crohns Colitis 2020;14:S798\u2013S806.","journal-title":"J Crohns Colitis"},{"key":"7040_CR3","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.cgh.2020.04.071","volume":"18","author":"M Allocca","year":"2020","unstructured":"Allocca M, Fiorino G, Zallot C et al. Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts. Clin Gastroenterol Hepatol 2020;18:2134\u20132135.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7040_CR4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.12.066","author":"A Papa","year":"2021","unstructured":"Papa A, Gasbarrini A, Lopetuso LR. Winter is coming and COVID-19 vaccine is available! The role of gastroenterologist in increasing COVID-19 vaccine acceptability among IBD patients. Gastroenterology. 2021. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.066.","journal-title":"Gastroenterology"},{"key":"7040_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet 2021;397:99\u2013111.","journal-title":"The Lancet"},{"key":"7040_CR6","unstructured":"The British Society of Gastroenterology. British Society of Gastroenterology Inflammatory Bowel Disease Section and IBD Clinical Research Group position statement on SARS-CoV2 Vaccination. January 4, 2021. https:\/\/www.bsg.org.uk\/covid-19-advice\/british-society-of-gastroenterology-inflammatory-bowel-disease-section-and-ibd-clinical-research-group-position-statement-on-sars-cov2-vaccination\/"},{"key":"7040_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-324000","author":"CA Siegel","year":"2021","unstructured":"Siegel CA, Melmed GY, McGovern DP, et al. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2020-324000","journal-title":"Gut"},{"key":"7040_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.02.004","author":"RS Dalal","year":"2021","unstructured":"Dalal RS, McClure E, Marcus J, et al. COVID-19 vaccination intent and perceptions among patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2021.02.004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7040_CR9","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.vaccine.2014.01.081","volume":"32","author":"HJ Larson","year":"2014","unstructured":"Larson HJ, Jarrett C, Eckersberger E et al. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007\u20132012. Vaccine 2014;32:2150\u20132159.","journal-title":"Vaccine"},{"key":"7040_CR10","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1016\/j.vaccine.2018.03.063","volume":"36","author":"S Lane","year":"2018","unstructured":"Lane S, MacDonald NE, Marti M, Dumolard L. Vaccine hesitancy around the globe: analysis of three years of WHO\/UNICEF joint reporting form data-2015\u20132017. Vaccine 2018;36:3861\u20133867.","journal-title":"Vaccine"},{"key":"7040_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00038-020-01404-4","volume":"65","author":"M Fadda","year":"2020","unstructured":"Fadda M, Albanese E, Suggs LS. When a COVID-19 vaccine is ready, will we all be ready for it? Int J Public Health 2020;65:711\u2013712.","journal-title":"Int J Public Health"},{"key":"7040_CR12","unstructured":"Sant\u00e9 Publique France. COVID-19\u202f: point \u00e9pid\u00e9miologique du 25 f\u00e9vrier 2021. Accessed March 3, 2021.  https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/maladies-et-infections-respiratoires\/infection-a-coronavirus\/documents\/bulletin-national\/covid-19-point-epidemiologique-du-25-fevrier-2021."},{"key":"7040_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00420-w","author":"F D\u2019Amico","year":"2021","unstructured":"D\u2019Amico F, Rabaud C, Peyrin-Biroulet L, Danese S. SARS-CoV-2 vaccination in IBD: more pros than cons. Nat Rev Gastroenterol Hepatol. 2021. https:\/\/doi.org\/10.1038\/s41575-021-00420-w.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7040_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","volume":"27","author":"JV Lazarus","year":"2021","unstructured":"Lazarus JV, Ratzan SC, Palayew A et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med 2021;27:225\u2013228.","journal-title":"Nat Med"},{"key":"7040_CR15","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1016\/j.vaccine.2020.08.043","volume":"38","author":"PL Reiter","year":"2020","unstructured":"Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine 2020;38:6500\u20136507.","journal-title":"Vaccine"},{"key":"7040_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/MIB.0000000000001013","volume":"23","author":"S Coenen","year":"2017","unstructured":"Coenen S, Weyts E, Jorissen C et al. Effects of education and information on vaccination behavior in patients with inflammatory bowel disease. Inflamm Bowel Dis 2017;23:318\u2013324.","journal-title":"Inflamm Bowel Dis"},{"key":"7040_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/apt.15057","volume":"49","author":"J Sitte","year":"2019","unstructured":"Sitte J, Frentiu E, Baumann C et al. Vaccination for influenza and pneumococcus in patients with gastrointestinal cancer or inflammatory bowel disease: a prospective cohort study of methods for improving coverage. Aliment Pharmacol Ther 2019;49:84\u201390.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07040-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07040-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07040-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T16:06:05Z","timestamp":1654358765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07040-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7040"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07040-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"26 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B Caron and E Neuville declare no conflict of interest. L Peyrin-Biroulet has served as a speaker, consultant, and advisory board member for Merck, Abbvie, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillots, Vifor, Hospira\/Pfizer, Celltrion, Takeda, Biogaran, Boerhinger-Ingelheim, Lilly, HAC- Pharma, Index Pharmaceuticals, Amgen, Sandoz, For- ward Pharma GmbH, Celgene, Biogen, Lycera, Samsung Bioepis, Theravance.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}